Skip to content
Advertisement

FILE - In this Nov. 2, 2017, file photo, Cameron McNamee, Ohio Board of Pharmacy director of policy and communications, speaks at a news conference. The Ohio Pharmacy Board announced July 29, 2020, a prohibition on prescribing hydroxychloroquine for individuals with COVID-19. The board reversed itself one day later at the request of Gov. Mike DeWine. The pharmacy board received more than 1,400 emails and more than 400 voicemails in a day. The responses reviewed by The Associated Press show people furious that the board placed the drug off limits. McNamee said the pharmacy board is now reassessing its decisions. He acknowledged that "people were maybe a little perturbed that we came between them and their doctor." (AP Photo/Andrew Welsh-Huggins, File)

FILE - In this Nov. 2, 2017, file photo, Cameron McNamee, Ohio Board of Pharmacy director of policy and communications, speaks at a news conference. The Ohio Pharmacy Board announced July 29, 2020, a prohibition on prescribing hydroxychloroquine for individuals with COVID-19. The board reversed itself one day later at the request of Gov. Mike DeWine. The pharmacy board received more than 1,400 emails and more than 400 voicemails in a day. The responses reviewed by The Associated Press show people furious that the board placed the drug off limits. McNamee said the pharmacy board is now reassessing its decisions. He acknowledged that "people were maybe a little perturbed that we came between them and their doctor." (AP Photo/Andrew Welsh-Huggins, File)

Featured Photo Galleries